At 4 to 5 half lives the concentration of drug in blood is

Questions 32

ATI RN

ATI RN Test Bank

ATI Pharmacology Made Easy 4.0 Infection Questions

Question 1 of 5

At 4 to 5 half lives the concentration of drug in blood is

Correct Answer: A

Rationale: The concentration of a drug in the blood decreases by half with each half-life. Thus, after 4 to 5 half-lives, the amount of drug remaining in the blood would be approximately 6.25% to 3.125% of the original concentration. This translates to the concentration being around 50% or less, making the correct answer A. 50%.

Question 2 of 5

Lithium is used to?

Correct Answer: C

Rationale: Lithium is commonly used as a mood stabilizer in the treatment of bipolar disorder. It helps reduce the intensity of manic episodes, thereby stabilizing the patient's mood and preventing extreme mood swings. While lithium is primarily known for its mood-stabilizing effects, it is not used to lower blood glucose, slow the heart, or heal ulcers.

Question 3 of 5

What is the category class of Iron?

Correct Answer: C

Rationale: Iron is classified as an Antianemic agent. Anemia is a condition characterized by a lack of healthy red blood cells, which are responsible for carrying oxygen to the body's tissues. Iron is essential for the production of hemoglobin, the protein in red blood cells that binds oxygen. Therefore, iron supplements are commonly used to treat iron-deficiency anemia by replenishing the body's iron stores and supporting the production of healthy red blood cells.

Question 4 of 5

The following drugs have an elimination half-life of less than 4 hours in a healthy adult:

Correct Answer: A

Rationale: Dopamine has a short half-life due to rapid metabolism by monoamine oxidases and catechol-O-methyltransferase, while others have longer half-lives.

Question 5 of 5

The patient is scheduled to receive a medication that is an enzyme inducer of the P450 system. What best describes the effect of this medication on the patient?

Correct Answer: C

Rationale: A P450 enzyme inducer (e.g., rifampin) speeds metabolism of itself and other drugs, reducing its own effect over time as levels drop faster, requiring dose adjustments. No effect on others is extreme-some drugs' metabolism increases, lowering their effect. Increased effects suggest inhibition, not induction. Self-induction lowers efficacy, a pharmacokinetic principle affecting long-term use.

Access More Questions!

ATI RN Basic


$89/ 30 days

 

ATI RN Premium


$150/ 90 days

 

Similar Questions